Monomorphic epithelial proliferations: Characterization and evidence suggesting they are the pool of partially transformed lesions from which some invasive carcinomas arise

American Journal of Clinical Pathology

Volumn 128, Issue 6, 2007, Pages 1023-1034

  Goldstein, Neal S ^a   Kestin, Larry J ^a   Vicini, Frank A ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Breast; Ductal carcinoma in situ; Hyperplasia; Molecular diagnostics; Monomorphic epithelial proliferations; Neoplastic cell transformation; Precursors

Indexed keywords

ADULT; AGED; ALLELIC IMBALANCE; ARTICLE; BREAST CARCINOMA; BREAST DISEASE; BREAST HYPERPLASIA; CANCER RADIOTHERAPY; CANCER RECURRENCE; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; INVASIVE CARCINOMA; IPSILATERAL BREAST FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; BREAST TUMOR; CELL CLONE; CELL TRANSFORMATION; FEMALE; GENETICS; HETEROZYGOSITY LOSS; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; POLYMERASE CHAIN REACTION; PRECANCER; SEGMENTAL MASTECTOMY; TUMOR RECURRENCE;

DNA; MICROSATELLITE DNA;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CLONE CELLS; DNA, NEOPLASM; EPITHELIAL CELLS; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MASTECTOMY, SEGMENTAL; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS;

EID: 38049003524     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/YU37DVCUFUHP8VPY     Document Type: Article

References (76)

1. Early Breast Trialists' Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet. 2005;366:2087-2106.
2. Lim M, Bellon JR, Gelman R, et al. A prospective study of conservative surgery without radiation therapy in select patients with stage I breast cancer. Int J Radiat Oncol Biol Phys. 2006;65:1149-1154.
3. Park CC, Mitsumori M, Nixon A, et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol. 2000;18:1668-1675.
4. Goldstein NS, Vicini FA, Hunter S, et al. Molecular clonality determination of ipsilateral recurrence of invasive breast carcinomas after breast-conserving therapy: comparison with clinical and biologic factors. Am J Clin Pathol. 2005;123:679-689.
5. Goldstein NS, Vicini FA, Hunter S, et al. Molecular clonality relationships in initial carcinomas, ipsilateral breast failures, and distant metastases in patients treated with breast-conserving therapy: evidence suggesting that some distant metastases are derived from ipsilateral breast failures and that metastases can metastasize. Am J Clin Pathol. 2005;124:49-57.
6. Goldstein NS, Kestin L, Vicini F. Factors associated with ipsilateral breast failure and distant metastases in patients with invasive breast carcinoma treated with breast-conserving therapy: a clinicopathologic study of 607 neoplasms from 583 patients. Am J Clin Pathol. 2003;120:500-527.
7. Simpson PT, Reis-Filho JS, Gale T, et al. Molecular evolution of breast cancer. J Pathol. 2005;205:248-254.
8. Boecker W, Moll R, Dervan P, et al. Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ. J Pathol. 2002;198:458-467.
9. Abdel-Fatah TM, Powe DG, Hodi Z, et al. High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Am J Surg Pathol. 2007;31:417-426.
10. Dabbs DJ, Carter G, Fudge M, et al. Molecular alterations in columnar cell lesions of the breast. Mod Pathol. 2006;19:344-349.
11. Fraser JL, Raza S, Chorny K, et al. Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications. Am J Surg Pathol. 1998;22:1521-1527.
12. Simpson PT, Gale T, Reis-Filho JS, et al. Columnar cell lesions of the breast: the missing link in breast cancer progression? a morphological and molecular analysis. Am J Surg Pathol. 2005;29:734-746.
13. Ellis IO, Schnitt SJ, Sastre-Garau X, et al. Tumours of the breast. In: Tavassoli FA, Devilee P, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon, France: IARC Press; 2005:9-112.
14. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer, I: the value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19:403-410.
15. Sieben NL, Kolkman-Uljee SM, Flanagan AM, et al. Molecular genetic evidence for monoclonal origin of bilateral ovarian serous borderline tumors. Am J Pathol. 2003;162:1095-1101.
16. Kusama R, Fujimori M, Matsuyama I, et al. Clinicopathological characteristics of atypical cystic duct (ACD) of the breast: assessment of ACD as a precancerous lesion. Pathol Int. 2000;50:793-800.
17. Oyama T, Maluf H, Koerner F. Atypical cystic lobules: an early stage in the formation of low-grade ductal carcinoma in situ. Virchows Arch. 1999;435:413-421.
18. Oyama T, Iijima K, Takei H, et al. Atypical cystic lobule of the breast: an early stage of low-grade ductal carcinoma in-situ. Breast Cancer. 2000;7:326-331.
19. Schnitt SJ. The diagnosis and management of pre-invasive breast disease: flat epithelial atypia: classification, pathologic features and clinical significance. Breast Cancer Res. 2003;5:263-268.
20. Schnitt SJ, Vincent-Salomon A. Columnar cell lesions of the breast. Adv Anat Pathol. 2003;10:113-124.
21. Schnitt SJ. Flat epithelial atypia. In: Boecker W, ed. Preneoplasia of the Breast: A New Conceptual Approach to Proliferative Breast Disease. Munich, Germany: Saunders; 2006:369-378.
22. Lakhani SR, Chaggar R, Davies S, et al. Genetic alterations in "normal" luminal and myoepithelial cells of the breast. J Pathol. 1999;189:496-503.
23. Boecker W, Buerger H, Schmitz K, et al. Ductal epithelial proliferations of the breast: a biological continuum? comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns. J Pathol. 2001;195:415-421.
24. Walker RA. Are all ductal proliferations of the breast premalignant? J Pathol. 2001;195:401-403.
25. Ellis IO, Pinder SE, Lee AH, et al. A critical appraisal of existing classification systems of epithelial hyperplasia and in situ neoplasia of the breast with proposals for future methods of categorization: where are we going? Semin Diagn Pathol. 1999;16:202-208.
26. Buerger H, Mommers EC, Littmann R, et al. Correlation of morphologic and cytogenetic parameters of genetic instability with chromosomal alterations in in situ carcinomas of the breast. Am J Clin Pathol. 2000;114:854-859.
27. Shoker BS, Jarvis C, Sibson DR, et al. Oestrogen receptor expression in the normal and pre-cancerous breast. J Pathol. 1999;188:237-244.
28. Buerger H, Otterbach F, Simon R, et al. Comparative genomic hybridization of ductal carcinoma in situ of the breast: evidence of multiple genetic pathways. J Pathol. 1999;187:396-402.
29. Buerger H, Simon R, Schäfer KL, et al. Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Mol Pathol. 2000;53:118-121.
30. Pinder SE, Reis-Filho JS. Non operative breast pathology: columnar cell lesions. J Clin Pathol. 2006. doi: 10.1136/jcp.2006.040634.
31. Noel JC, Fayt I, Fernandez-Aguilar S, et al. Proliferating activity in columnar cell lesions of the breast. Virchows Arch. 2006;449:617-621.
32. Azzopardi JG. Underdiagnosis of malignancy. In: Problems in Breast Pathology. Philadelphia, PA: Saunders; 1979:192-213.
33. Rosen PP. Columnar cell hyperplasia is associated with lobular carcinoma in situ and tubular carcinoma [letter]. Am J Surg Pathol. 1999;23:1561.
34. Lee S, Mohsin SK, Mao S, et al. Hormones, receptors, and growth in hyperplastic enlarged lobular units: early potential precursors of breast cancer. Breast Cancer Res. 2006;8:R6.
35. Boecker W, Buerger H, Herbst H, et al. Basic principles of precursor lesions of breast cancer. In: Boecker W, ed. Preneoplasia of the Breast: A New Conceptual Approach to Proliferative Breast Disease. Munich, Germany: Saunders; 2006:337-368.
36. Boecker W, Buerger H, Herbst H, et al. Basic principles of benign proliferative breast disease. In: Boecker W, ed. Preneoplasia of the Breast: A New Conceptual Approach to Proliferative Breast Disease. Munich, Germany: Saunders; 2006:129-144.
37. Russo J, Balogh GA, Chen J, et al. The concept of stem cell in the mammary gland and its implication in morphogenesis, cancer and prevention. Front Biosci. 2006;11:151-172.
38. Savarese TM, Low HP, Baik I, et al. Normal breast stem cells, malignant breast stem cells, and the perinatal origin of breast cancer. Stem Cell Rev. 2006;2:103-110.
39. Dontu G, Al-Hajj M, Abdallah WM, et al. Stem cells in normal breast development and breast cancer. Cell Prolif. 2003;36(suppl 1):59-72.
40. Liu BY, McDermott SP, Khwaja SS, et al. The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells. Proc Natl Acad Sci U S A. 2004;101:4158-4163.
41. Kalirai H, Clarke RB. Human breast epithelial stem cells and their regulation. J Pathol. 2006;208:7-16.
42. Tot T. DCIS, cytokeratins, and the theory of the sick lobe. Virchows Arch. 2005;447:1-8.
43. Fridriksdottir AJ, Villadsen R, Gudjonsson T, et al. Maintenance of cell type diversification in the human breast. J Mammary Gland Biol Neoplasia. 2005;10:61-74.
44. Diallo R, Schaefer KL, Poremba C, et al. Monoclonality in normal epithelium and in hyperplastic and neoplastic lesions of the breast. J Pathol. 2001;193:27-32.
45. Tsai YC, Lu Y, Nichols PW, et al. Contiguous patches of normal human mammary epithelium derived from a single stem cell: implications for breast carcinogenesis. Cancer Res. 1996;56:402-404.
46. Russo J, Lynch H, Russo IH. Mammary gland architecture as a determining factor in the susceptibility of the human breast to cancer. Breast J. 2001;7:278-291.
47. Russo J, Tahin Q, Lareef MH, et al. Neoplastic transformation of human breast epithelial cells by estrogens and chemical carcinogens. Environ Mol Mutagen. 2002;39:254-263.
48. Milanese TR, Hartmann LC, Sellers TA, et al. Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst. 2006;98:1600-1607.
49. Walker RA, Martin CV. The aged breast. J Pathol. 2007;211:232-240.
50. Avivar A, Garcia-Macias MC, Ascaso E, et al. Moderate overexpression of AIB1 triggers pre-neoplastic changes in mammary epithelium. FEBS Lett. 2006;580:5222-5226.
51. Larson PS, de Las MA, Cerda SR, et al. Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursors. J Pathol 2006;209:307-316.
52. Li Z, Meng ZH, Sayeed A, et al. Genome-wide allelotyping of a new in vitro model system reveals early events in breast cancer progression. Cancer Res. 2002;62:5980-5987.
53. Shaaban AM, Sloane JP, West CR, et al. Breast cancer risk in usual ductal hyperplasia is defined by estrogen receptor-alpha and Ki-67 expression. Am J Pathol. 2002;160:597-604.
54. Meeker AK, Hicks JL, Gabrielson E, et al. Telomere shortening occurs in subsets of normal breast epithelium as well as in situ and invasive carcinoma. Am J Pathol. 2004;164:925-935.
55. Meeker AK, Argani P. Telomere shortening occurs early during breast tumorigenesis: a cause of chromosome destabilization underlying malignant transformation? J Mammary Gland Biol Neoplasia. 2004;9:285-296.
56. Böcker W, Moll R, Poremba C, et al. Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages: a new cell biological concept. Lab Invest. 2002;82:737-746.
57. Bankfalvi A, Ludwig A, De-Hesselle B, et al. Different proliferative activity of the glandular and myoepithelial lineages in benign proliferative and early malignant breast diseases. Mod Pathol 2004;17:1051-1061.
58. Greenberg RA. Telomeres, crisis and cancer. Curr Mol Med. 2005;5:213-218.
59. Romanov SR, Kozakiewicz BK, Holst CR, et al. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature. 2001;409:633-637.
60. Esteller M. Aberrant DNA methylation as a cancer-inducing mechanism. Annu Rev Pharmacol Toxicol. 2005;45:629-656.
61. Venkitaraman AR. Chromosomal instability and breast cancer pathogenesis. J Mammary Gland Biol Neoplasia. 2004;9:217-220.
62. McDermott KM, Zhang J, Holst CR, et al. p16(INK4a) prevents ccntrosome dysfunction and genomic instability in primary cells. PLoS Biol. 2006;4:e51. doi: 10.1371/journal.pbio.0040051.
63. Soler D, Genesca A, Arnedo G, et al. Telomere dysfunction drives chromosomal instability in human mammary epithelial cells. Genes Chromosomes Cancer. 2005;44:339-350.
64. Bailey SM, Murnane JP. Telomeres, chromosome instability and cancer. Nucleic Acids Res. 2006;34:2408-2417.
65. Yaswen P, Stampfer MR. Molecular changes accompanying senescence and immortalization of cultured human mammary epithelial cells. Int J Biochem Cell Biol. 2002;34:1382-1394.
66. Li Y, Pan J, Li JL, et al. Transcriptional changes associated with breast cancer occur as normal human mammary epithelial cells overcome senescence barriers and become immortalized. Mol Cancer. 2007;6:7.
67. Lewis CM, Cler LR, Bu DW, et al. Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk. Clin Cancer Res. 2005;11:166-172.
68. Yan PS, Venkataramu C, Ibrahim A, et al. Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue. Clin Cancer Res. 2006;12:6626-6636.
69. Crawford YG, Gauthier ML, Joubel A, et al. Histologically normal human mammary epithelia with silenced p16(INK4a) over express COX-2, promoting a premalignant program. Cancer Cell. 2004;5:263-273.
70. Tlsty TD, Crawford YG, Holst CR, et al. Genetic and epigenetic changes in mammary epithelial cells may mimic early events in carcinogenesis. J Mammary Gland Biol Neoplasia. 2004;9:263-274.
71. Berman H, Zhang J, Crawford YG, et al. Genetic and epigenetic changes in mammary epithelial cells identify a subpopulation of cells involved in early carcinogenesis. Cold Spring Harb Symp Quant Biol. 2005;70:317-327.
72. Chin K, de Solorzano CO, Knowles D, et al. In situ analyses of genome instability in breast cancer. Nat Genet. 2004;36:984-988.
73. Slater M, Danieletto S, Pooley M, et al. Differentiation between cancerous and normal hyperplastic lobules in breast lesions. Breast Cancer Res Treat. 2004;83:1-10.
74. Luna-More S, Weil B, Bautista D, et al. Bcl-2 protein in normal, hyperplastic and neoplastic breast tissues: a metabolite of the putative stem-cell subpopulation of the mammary gland. Histol Histopathol 2004;19:457-463.
75. Lakhani SR, Slack DN, Hamoudi RA, et al. Detection of allelic imbalance indicates that a proportion of mammary hyperplasia of usual type are clonal, neoplastic proliferations. Lab Invest. 1996;74:129-155.
76. Jones C, Merrett S, Thomas VA, et al. Comparative genomic hybridization analysis of bilateral hyperplasia of usual type of the breast. J Pathol. 2003;199:152-156.